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Abstract Circular DNA molecules can readily be formed from 
the 169 bp tyrT fragment in the presence of T4 DNA ligase. We 
have analyzed the formation of DNA circles in the presence of 
the clinically important antitumour drugs amsacrine, mitoxan- 
trone and daunomycin. All three are intercalating agents but they 
affect the closure reaction differently: daunomycin and mitox- 
antrone progressively inhibit the formation of circles whereas at 
low concentrations amsacrine strongly enhances the yield of 
circles suggesting that this drug can increase the flexibility and/ 
or curvature of DNA. The ligation assay described here may 
prove useful and widely applicable for investigating the effects of 
small molecules on the secondary structure of DNA. 
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can interfere with the biological functions of DNA by inhibit- 
ing protein-induced bending or by mimicking an intrinsic or 
protein-induced curvature. These considerations have 
prompted us to develop a simple assay to evaluate the effects 
of DNA-binding ligands on secondary structure and DNA 
curvature/flexibility in particular. The assay described in this 
paper is based on the circularisation of the 169 base pair tyrT 
DNA fragment in the presence of DNA ligase and depends 
upon measuring the extent to which small molecules interfere 
with the formation of circular DNA molecules. Results ob- 
tained with the antitumour drugs daunomycin, mitoxantrone 
and amsacrine are reported. 
2. Materials and methods 
1. Introduction 
Upon binding to DNA certain proteins such as the catabo- 
lite gene activator protein (CAP), the integration host factor 
( IHF) and the factor for inversion stimulation (FIS) induce a 
bending of the double helix [1,2]. The DNA bends induced by 
such proteins are often specifically required for the initiation 
of transcription or site-specific recombination as well as other 
enzymatic processes. The phenomenon of DNA curvature/ 
flexibility and its relation to DNA supercoiling and packaging 
is a crucial determinant of both the function and architecture 
of protein-DNA complexes [3]. 
DNA bending can also be induced by peptides and small 
molecules. Moreover, it is an intrinsic characteristic of DNA 
molecules containing certain sequences uch as adenine-thy- 
mine tracts [4,5]. The intrinsic flexibility of particular DNA 
sequences contributes importantly to the target-site selection 
by DNA-bending ligands [6,7]. Bending and other structural 
distortions of DNA induced by small molecules are likely to 
represent an essential part of their mechanism of action. The 
antibiotics actinomycin and mithramycin, which are fre- 
quently used in chemotherapy of cancer, bend the DNA 
into the major groove upon binding to the minor groove of 
GC-rich sequences [8,9]. On the other hand, the antibiotic 
CC-1065 bends the helix axis towards the minor groove 
upon covalent attachment into that groove [10,11]. Other anti- 
tumour drugs such as ditercalinium and bizelesin can recog- 
nize and straighten out bent DNA [12,13]. Evidently, drugs 
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2.1. Drugs and enzymes 
Mitoxantrone (Novantrone) was obtained from Laboratoires L6- 
derl6 (Oullins, France). Amsacrine and daunomycin were purchased 
from Sigma Chemical Co. (La Verpillibre, France). Enzymes EcoRI, 
alkaline phosphatase, T4 polynucleotide kinase, T4 DNA ligase and 
exonuclease III were purchased from Boehringer (Mannheim, Ger- 
many) and used according to the supplier's recommended protocol 
in the activity buffer provided. 
2.2. Purification and labelling of the tyrT fragment 
The plasmid pKMp27 [14,15] containing the EcoRI-EcoRI 169 bp 
tyrT fragment was obtained by courtesy of Dr. A.A. Travers (MRC 
Laboratory of Molecular Biology, Cambridge, UK). The plasmid was 
isolated from E. coli by a standard SDS-NaOH lysis procedure and 
purified by banding in CsCl-ethidium bromide gradients. It was cut 
with EeoRI, treated with alkaline phosphatase and then labelled at the 
two protruding 5'-termini using T4 polynucleotide kinase (Pharmacia) 
and [y-s2p]ATP (6000 Ci/mmol, Amersham). The labelled tyrT frag- 
ment was purified by electrophoresis. 
2.3. Formation of DNA circles 
In a typical experiment, each sample contained 1111 of :~2p-labelled 
DNA (approx. 0.3 lag/ml, 50 counts per s), 6 111 of water, 10 ~tl of drug 
at the desired concentration (or water in the controls) and 2 tll of 
10 x ligase buffer. After 30 min incubation to ensure quilibration, 1 111 
(5 units) of ligase was added to each tube and the reaction was con- 
tinued at room temperature for 1-60 min (generally 20 min when 
testing a drug). The ligase was then denatured by heating at 65°C 
for 5 min and samples were immediately electrophoresed. To verify 
that the ligation products corresponded to circular DNA molecules, 
1 ~tl of exonuclease III (100 units) was added to the ligase-treated 
sample (after heat denaturation of the ligase) and incubated for 30 
min at 37°C prior to electrophoresis. 
2.4. Eleetrophoresis and data analysis 
Ligation products were separated by polyacrylamide gel electro- 
phoresis under native conditions (6% acrylamide gels, 1.5 mm thick). 
Electrophoresis was carried out for about 1.5 h at 150 V in TBE 
buffer. Gels were transferred to Whatman 3MM paper, dried under 
vacuum and scanned with a Molecular Dynamics 445SI Phosphor- 
Imager using ImageQuant version 4.1 software. Data in Figs. 2 and 4 
were compiled from quantitative analysis of three independent gels 
such as those shown in Figs. 1 and 3, respectively, and must be 
considered as a set of averaged values. 
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Fig. 1. Time dependence of ligation of the 169 bp tyrT DNA into 
circular molecules. The 5'-end labelled restriction fragment was in- 
cubated with the ligase for various lengths of time (0.1 60 min) and 
the samples were subjected to electrophoresis on a 6% non-denatur- 
ing gel. The starting material, incubated without ligase, is shown in 
the track labelled 'DNA'. The monomeric and dimeric circular 
products are resistant o digestion by exonuclease III (lane lig+exo 
III). 
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Fig. 2. Time course of formation of monomeric ircular DNA (e) 
upon treatment of linear DNA (• )  in the presence of T4 DNA li- 
gase. Band intensities (%) were determined by densitometric analysis 
of three autoradiograms like the one shown in Fig. 1. 
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Fig. 3. Effects of intercalating drugs on the formation of circular DNA. The drug concentration (t.tM) is indicated at the top of each gel lane. 
The linear DNA was exposed to drug for 30 min prior to reaction with the ligase for 20 min. The ligation products were separated by electro- 
o phoresis on a 6~, non-denaturing gel. 
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Fig. 4. Comparison of the production of circular molecules (©,O) 
from linear tyrT DNA ( A •)  in the presence of increasing concen- 
trations of mitoxantrone and amsacrine. Band intensities were deter- 
mined by densitometric analysis of three autoradiograms like that 
shown in Fig. 3. 
3. Results and discussion 
Initial experiments were performed in the absence of drug 
in order to establish optimal conditions for the formation of 
DNA circles. The 169 bp tyrT fragment was incubated with 
various amounts of ligase for different periods of time at room 
temperature and the ligation products were separated by elec- 
trophoresis (Fig. 1). Under the experimental conditions 
adopted, three DNA species were obtained: the unreacted 
169 bp linear DNA and two types of circular DNA molecules 
which migrate much more slowly than the linear DNA in the 
polyacrylamide gel. These two products can be identified as 
circles by their complete resistance to digestion by exonuclease 
III. They correspond to the monomeric 169 bp circle and the 
dimeric 338 bp circle, which both give rise to a single product 
that comigrates with the linear starting material upon redi- 
gesting the ligation products with EcoRI (not shown). Large 
quantities of circular DNA can thus be obtained when using a 
very low concentration f nucleic acid ( < 0.02 ~tg/ml) so as to 
avoid the formation of linear dimers. The formation of the 
circular DNA molecules i  time-dependent. As shown in Fig. 
2, more than 80% of the starting material is converted into 
circular products after 20 min reaction. Monomeric DNA 
circles are formed rapidly, within 15-30 min. Accordingly 
for subsequent experiments in the presence of drugs the 
same DNA samples were incubated with the ligase for 20 
min so as to obtain 40-60% circular DNA in the controls. 
Under these conditions, both an increase and a decrease in the 
formation of circles in the presence of the test drug can be 
detected. 
Fig. 3 shows typical gels which illustrate the results of re- 
acting the linear tyrT fragment with DNA ligase in the pres- 
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ence of increasing concentrations of the antitumour drugs 
amsacrine, mitoxantrone and daunomycin. One can immedi- 
ately see that these three drugs exert different effects on the 
circularization of the fragment. Both mitoxantrone and dau- 
nomycin strongly inhibit the formation of circles. In contrast, 
at low concentrations amsacrine increases the yield of circles 
but inhibits the ligation at concentrations ->10 gM. The dif- 
ferences between amsacrine and mitoxantrone are plainly evi- 
dent from the quantitative analysis hown in Fig. 4. The ob- 
servation that these two intercalating agents interfere 
differently with the closure reaction suggests that they exert 
different effects on DNA structure. Their inhibitory effects on 
the circularisation are unlikely to result from direct interfer- 
ence with the ligase itself because the level of inhibition was 
not particularly affected by varying the enzyme concentration, 
through we cannot formally exclude the possibility from these 
experiments. Moreover, the inhibition is not likely to result 
from drug binding to the true substrates of reaction, i.e. the 
single-stranded nds of the tyrT fragment, given the known 
preference of intercalators for binding to double helical DNA 
[16]. Far more likely is the proposition that the observed 
effects arise from multiple interactions with the DNA mole- 
cule so as to alter the ease with which its ends can become 
apposed. 
All three antitumour drugs tested here are classical interca- 
lating agents. Daunomycin, mitoxantrone and amsacrine un- 
wind the DNA double helix by 12-18 ° [16,17] and provoke an 
elongation of the DNA helix at the intercalation site in order 
to insert heir planar chromophore between two adjacent base 
pairs. The inhibition of synthesis of DNA circles observed 
with the drugs is thus easily attributable to the lengthening 
and straightening effects which are associated with the inter- 
calation process. More interesting is the observation that at 
concentrations -<5 gM amsacrine favours the formation of 
DNA circles. This suggests that the intercalation of its acri- 
dine chromophore may be accompanied by a slight increase in 
DNA flexibility and/or curvature of the double helix. This 
peculiar effect of amsacrine on DNA structure could well be 
a prelude to its effect on enzyme-mediated DNA metabolism 
and hence to its antitumour activity. While the bending of 
DNA by amsacrine remains peculative at present, it is en- 
tirely possible that some such subtle effect on DNA structure 
contributes to the mechanism by which the drug inhibits rep- 
licative events. Then the different effects observed with amsa- 
crine compared to mitoxantrone and daunomycin could ex- 
plain why, despite their generally assumed common mode of 
action (i.e. stabilization of topoisomerase II-DNA complexes), 
there are significant differences in the mechanism by which 
these drugs interfere with DNA metabolism [18,19]. At all 
events, the present results serve to indicate the general utility 
of the ligation assay described here as a means of detecting 
possible effects of small molecules on DNA secondary struc- 
ture, including its curvature and flexibility. This simple and 
rapid test may prove useful in screening experiments o com- 
pare novel series of drugs. 
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